Skip to main content

STRATEC Value Stock - Dividend - Research Selection

STRATEC Biomedical

ISIN: DE000STRA555, WKN: STRA55

Market price date: 22.05.2020
Market price: 83,30 EUR




STRATEC Biomedical Fundamental data and company key figures of the share

Annual reports in EUR
Key figures 08-04-2020
Cash flow
Net operating cash flow 21.262.000
Capital Expenditures -26.846.000
Free cash flow -5.584.000
Balance sheet
Total Equity 159.007.000
Liabilities & Shareholders equity 299.414.000
Income statement
Net income 14.440.000
Eps (diluted) 1,200
Diluted shares outstanding 12.033.300
Net sales/revenue 221.641.000

Fundamental ratios calculated on: 22-05-2020

Ratios
Key figures 22-05-2020
Cash flow
P/C 47,14
   
P/FC -179,51
Balance sheet
ROI4,82
ROE53,11
Income statement
P/E69,42
Div. Yield1,01%
P/B6,30
P/S4,52


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
SymbolSBS.DE
Market Capitalization1.092.982.144,00 USD
CountryGermany
IndicesCDAX,Prime All Share
SectorsBiotechnology
Raw Data SourceIFRS in Millionen EUR
Stock Split2006-07-31,2.0000/1.0000; 2000-10-11,3.0000/1.0000
Internetwww.stratec-biomedical.de


Description of the company

STRATEC Biomedical AG designs and manufactures solutions for automated processes in the fields of in vitro diagnostics and life sciences in Germany and internationally. The company operates through three segments: Instrumentation, Diatron, and Consumables. The Instrumentation segment designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers. The Diatron segment offers systems, system components, consumables, and tests for the low throughput hematology and clinical chemistry applications. The Consumables segment develops and sells scientific materials, such as nucleic acid purification; and designs and manufactures smart consumables in the fields of diagnostics, life sciences, and medical technology. STRATEC Biomedical AG also develops workflow software for networking several analyzer systems, as well as develops and sells scientific materials and technologies. The company was formerly known as STRATEC Biomedical Systems AG and changed its name to STRATEC Biomedical AG in April 2011. STRATEC Biomedical AG was founded in 1979 and is headquartered in Birkenfeld, Germany.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov, www.stratec-biomedical.de